Eco Wave Power CEO Inna Braverman to Meet with APDL and Key Portuguese Subcontractors in August to Coordinate Breakwater Completion Timeline, Installation Readiness and Grid-Connection Extension for the...
CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform...
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform...
Wave Life Sciences: Q2 Earnings Snapshot
Dosing underway in Phase 2a multidose portion of the INLIGHT TM trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with obesity (BMI: 35-50 kg/m 2 ) and comorbidities; trial will also...
Barchart Research What to Expect from WVE Earnings WVE Generated July 29, 2026 Current Price $5.81 EPS Estimate $$-0.31 Consensus Rating Strong Buy Average Move 5.76% Wave Life Sciences: Can RNA Editing...
CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform...
CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of...
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing ...
TAIPEI, Taiwan , June 2, 2026 /PRNewswire/ -- Eco Wave Power Global AB (publ) (NASDAQ: WAVE), a leading onshore wave energy technology company, today announced that its technology was featured...